Oral Semaglutide's Fit After Bariatric Surgery: A Mechanistic Review
Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.
Study Design
Population
Patients who have undergone metabolic and bariatric surgery (MBS) and are experiencing weight regain and metabolic complications.
Intervention
Oral semaglutide, dose, route, and duration not specified.
Outcome
The review discusses the potential challenges and benefits of oral semaglutide in this population, focusing on biopharmaceutical hurdles and relevance to weight regain and metabolic complications.
Abstract
This perspective is crucial for understanding the potential challenges and benefits of using oral semaglutide in patients who have undergone MBS. It suggests that while the drug's mechanism of action is highly relevant for weight regain and metabolic complications, its oral formulation might face significant biopharmaceutical hurdles.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
